Stephen M. Pastores, MD, FACP, FCCP, FCCM

Stephen M. Pastores, MD, FACP, FCCP, FCCM

Intensivist

Titles

Director, Critical Care Medicine Fellowship Training & Research Programs

Clinical Expertise

Critical Care Medicine

Share

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Monday through Friday, 8:00 a.m. to 6:00 p.m., (Eastern time)
Accepted Insurance Providers

Dr. Pastores accepts the following list of insurance providers. Select your insurance provider to see more details.

Aetna

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (City of NY retirees only, starting 9/1/23)

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO

Blue Cross Blue Shield Federal Employee Program

Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO

Blue Cross Blue Shield New York

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS

Blue Cross Health Plus

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Carrum Health

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

Cigna

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Connecticare

Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO

Emblem

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Emblem Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Emblem Medicare Advantage

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO

Empire Blue Cross Medicare Advantage

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN

Empire Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Fidelis

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO

Fidelis Managed Medicaid & HARP

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Fidelis Medicare Advantage

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO

First Health

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO

Healthfirst

Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Healthfirst Medicare Advantage

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO

Healthsmart

Payor Type: Commercial
In Network Coverage Type(s): PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

Payor Type: Commercial
In Network Coverage Type(s): HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Medicare Advantage

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO

Husky CT Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Magnacare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO

Straight NJ Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Straight NY Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Medicare Part A&B (traditional Medicare)

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government

Multiplan/Beech Street/PHCS

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

MVP

Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP

Non-Participating Plans with Out of Network Benefits

Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD

Oscar

Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO

Oxford

Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO

World Trade Center Health Program (WTC)

Payor Type: Commercial
In Network Coverage Type(s): State Government

Qualcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Tricare

Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO

UMR

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS

United Healthcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, Lyceum-Northwestern College (Philippines)

Residencies

Metropolitan Hospital Center/New York Medical College

Fellowships

New York University Medical Center; Mount Sinai Medical Center (New York)

Board Certifications

Internal Medicine; Pulmonary Disease; Critical Care Medicine

I joined the Memorial Sloan Kettering staff in 1999 and have served as the director of the Critical Care Medicine Fellowship & Research Programs in the Department of Anesthesiology & Critical Care Medicine since 2003. As Fellowship Director, I am in charge of the day-to-day operation of the program, including the development and implementation of the educational curriculum for our fellows, and discussing their evaluations, research projects, and career options. I am also a professor of medicine in anesthesiology and medicine at Weill Cornell Medical College. I serve as Principal Investigator for several clinical trials in septic shock and acute lung injury. In addition to my clinical and research activities at MSK, I am actively involved in critical care medicine at a national level, serving as a member of the Board of Regents of the Society of Critical Care Medicine and a member of the editorial boards of CHEST Journal, Critical Care Medicine, and Journal of Critical Care. I was the recipient of the Distinguished Service Award and the Safar Global Partner Award from the Society of Critical Care Medicine for exceptional leadership contributions to the vision and mission of the Society. 

Awards and Honors

  • Castle Connolly: America's Top Doctors (2023)

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Anesthesiology and Critical Care Medicine doctors

See all Critical Care Medicine Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Pastores SM, Halpern NA, Oropello JM, Kvetan V. Critical care organizations in academic medical centers in North America: a descriptive report. Crit Care Med 2015 Oct;43(10):2239-44.

Halpern NA, Pastores SM. Critical care medicine beds, use, occupancy and costs in the United States: a methodological review. Crit Care Med Nov;43(11):2452-9.

Pastores SM, Halpern NA. Insights into ICU bed expansion in the US: national and regional analysis. Am J Respir Crit Care Med 2015;191(4):365-6.

Read more

Pastores SM, Halpern NA, Oropello JM, Kvetan V. Intensivist Workforce in the US: The Crisis is Real, Not Imagined. Am J Respir Crit Care Med 2015;191(6):718-9.

Pastores SM. Staffing ratios and workload in critically ill patients: do they impact outcomes. Crit Care Med 2015 Aug;43(8):1775-6.

Vadde R, Pastores SM. Management of acute respiratory failure in patients with hematologic malignancies. J Intensive Care Med 2015 Aug 16.

Paskovaty A, Pastores SM, Gedrimaite Z, Kostelecky N, Riedel E, Seo SK. Antimicrobial de-escalation in septic cancer patients: is it safe to back down? Intensive Care Med 2015; Nov;41:2022-3.

 

Kamat S, Chawla S, Rajendram P, Pastores SM, Kostelecky N, Halpern NA. An analysis of patients transferred to a tertiary oncological intensive care unit for defined procedures. Am J Crit Care 2015;24(3):241-7.

 

Pastores SM, DeSancho MT. Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients with similar costs. ACP Journal Club 2015;162(6):JC13.

Cheng B, Hoeft AH, Book M, Shu Q, Pastores SM. Sepsis: pathogenesis, biomarkers, and treatment. Biomed Res Int. 2015;2015:846935.

Pastores SM, Kvetan V. Shortage of intensive care specialists in the United States: recent insights and proposed solutions. Rev Bras Ter Intensiva. 2015 Jan-Mar;27(1):5-6.

Halpern NA, Pastores SM. Understanding the Russell equation and projection estimates to describe critical care costs in the USA. Intensive Care Med 2015 Oct;41(10):1828-30.

Sevransky JE, Checkley W, Herrera P, Pickering BW, Barr J, Brown SM, Chang SY, Chong D, Kaufman D, Fremont RD, Girard TD, Hoag J, Johnson SB, Kerlin MP, Liebler J, O’Brien J, O’Keefe T, Park PK, Pastores SM, Patil N, Pietropaoli AP, Putman M, Rice TW, Rotello L, Siner J, Sajid S, Murphy DJ, Martin GS; United States Critical Illness and Injury Trials Group-Critical Illness Outcomes Study Investigators. Protocols and Hospital Mortality in Critically Ill Patients: The United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study. Crit Care Med. 2015 Oct;43(10):2076-84

Mokart D, Pastores SM, Darmon M. Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 2014;40:1570-2. [pmid:25160033]

Fessler HE, Addrizzo-Harris D, Beck JM, Buckley JD, Pastores SM, Piquette CA, Rowley JA, Spevetz A. Entrustable Professional Activities and Curricular Milestones for Fellowship Training in Pulmonary and Critical Care Medicine: Report of a multi-society working group. Chest 2014;146(3):813-34. [pmid:24945874]

Joffe AM, Pastores SM, Maerz LL, Mathur P, Lisco SJ. Utilization and impact on fellowship training of non-physician advanced practice providers in intensive care units of academic medical centers: a survey of critical care program directors. J Crit Care. 2014 Feb;29(1):112-5. [pmid:24268625]

Pastores SM, Martin GS, Baumann MH, et al. Training internists to meet critical care needs in the United States: a consensus statement from the Critical Care Societies Collaborative (CCSC). CCSC Task Force on Critical Care Educational Pathways in Internal Medicine. Crit Care Med. 2014 May;42(5):1272-9. [pmid:24637881]

Pastores SM, DeSancho MT. Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients with similar costs. ACP Journal Club 2015;162(6):JC13. [pmid:25775344]

Cheng B, Hoeft AH, Book M, Shu Q, Pastores SM. Sepsis: pathogenesis, biomarkers, and treatment. Biomed Res Int. 2015;2015:846935. [pmid:25834828]

Pastores SM, Kvetan V. Shortage of intensive care specialists in the United States: recent insights and proposed solutions. Rev Bras Ter Intensiva. 2015 Jan-Mar;27(1):5-6. [pmid:25909306]

Kamat S, Chawla S, Rajendram P, Pastores SM, Kostelecky N, Halpern NA. An analysis of patients transferred to a tertiary oncological intensive care unit for defined procedures. Am J Crit Care. 2015 May;24(3):241-7. [pmid:25934721]

Pastores SM, Halpern NA. Insights into ICU bed expansion in the US: national and regional analysis. Am J Respir Crit Care Med 2015;191(4):365-6.

Pastores SM, Halpern NA, Oropello JM, Kvetan V. Intensivist Workforce in the US: The Crisis is Real, Not Imagined. Am J Respir Crit Care Med 2015;191(6):718-9. [pmid:25767929]

Pastores SM, Voigt LP. Acute respiratory failure in the patient with cancer: diagnostic and management strategies.. Critical Care Clinics 2010; 26 :21-40

Kirkland LL, Parham WM, Pastores SM. Approaching hospital administrators about adopting cooling technologies. Critical Care Medicine 2009; 37 :S290-4

Halpern NA, Pastores SM. Critical Care Medicine in the USA 2000-2005: an analysis of bed numbers, use, and costs. Critical Care Medicine 2009;

Pastores SM. Management of Pulmonary Embolism in the Intensive Care Unit. Journal of Critical Care 2009; 24 :185-91

Marik PE, Pastores SM, Kavanagh BP. Corticosteroids for septic shock. New England Journal of Medicine 2009; 358 :2069-70

Marik P, Myburgh J, Annane D, Vincent JL, Pastores S, Meduri GU, Beishuizen A. What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit?. Annals of Internal Medicine 2008; 149 :770-1

Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, et al.. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Critical Care Medicine 2008; 36 :1937-49

Halpern NA, Pastores SM, Thaler HT, Greenstein RJ. Critical care medicine use and cost among Medicare beneficiaries 1995-2000: major discrepancies between two U.S. federal Medicare databases. Critical Care Medicine 2007; 35 :692-9

Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA. Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients. Critical Care 2007; 11 :R48

Pastores SM, Shaw A, Williams MD, Mongan E, Alicea M, Halpern NA. A Safety Evaluation of Drotrecogin alfa (activated) in Hematopoietic Stem Cell Transplant Patients with Severe Sepsis: Lessons in Clinical Research. Bone Marrow Transplantation 2005;36:721-24.

Pastores SM, Papadopoulos E, van den Brink M, Alicea M, Halpern N: Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C. Bone Marrow Transplantation 2002;30:131-134.

Pastores SM. Technological Innovations in organ support for hepatic, renal and hematologic failure. NVIC (Netherlands Journal of Intensive Care) 2001;5:46-49.

Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, et al, Halpern N, Pastores SM et al of the Tenefuse Study Group. Crit Care Med 2001;29:503-510.

Pastores SM: Acute Respiratory Failure: Diagnosis and Management. Oncology and Critical Care. Critical Care Clinics of North America, Vol 17(3), July 2001, pp. 623-646.

Halpern NA, Pastores SM, Oropello JM (editors). ICU Bedside Technology. Critical Care Clinics of North America. Philadelphia: W.B. Saunders Company, 2000:545.

Maguire PJ, Stevens C, Humes HD, Shander A, Halpern NA, Pastores SM. Bioartificial Organ Support for Hepatic, Renal and Hematologic Failure. In Halpern NA, Pastores SM, Oropello JM, Eds, ICU Bedside Technology: A Look into the 21st Century, Critical Care Clinics of North America, Vol 16(4), October 2000, pp 681-694.

Pastores SM, Halpern NA. Acquisition Strategies for Critical Care Technology. In: Halpern NA, Pastores SM, Oropello JM, Eds, ICU Bedside Technology: A Look into the 21st Century, Critical Care Clinics of North America, Vol 16(4), October 2000, pp 545-556.

Pastores SM, Halpern N. Striving to get new technology into the critical care environment. Journal of Critical Illness 2000;15(7):351-357.

Halpern NA, Pastores SM, Baker-Price J, Alicea M. The many causes of acute hearing loss in the ICU. Clinical Update. J Crit Illness 1999;14:398-402.

 

Publications on PubMed

Visit PubMed for a full listing of Dr. Pastores’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Stephen M. Pastores discloses the following relationships and financial interests:

  • AbbVie
    Provision of Services
  • McGraw-Hill Education
    Intellectual Property Rights

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures